Abstract 1602P
Background
When a child has a life-limiting, irreversible condition such as advanced cancer, a healthcare team and family may decide to limit care lacking clear benefit. In such circumstances, a compassionate extubation, or discontinuation of life-sustaining ventilator support allowing natural death, may be pursued. Compassionate extubations are an infrequently performed procedure with complexities that include difficult conversations and dynamic symptom management which can lend to this being a challenging process to execute, particularly without opportunity for practice. Simulation can be a helpful tool to enhance knowledge, confidence, and preparedness with unfamiliar or uncommon scenarios in a safe environment. A compassionate extubation simulation training experience focusing on the conversational and technical skills was implemented within the Pediatric Intensive Care Unit at an academic medical center in New York City. The aim of the project was to determine whether participation in one simulation training improved healthcare providers’ confidence with performing a compassionate extubation.
Methods
A one group pretest-posttest design project was implemented using The Confidence Scale to evaluate RN and APRN confidence with performing a compassionate extubation before and after the simulation. The sample was described using descriptive statistical analysis and the Wilcoxon signed-rank test was used to evaluate for differences between first and second observations.
Results
A Wilcoxon signed-rank test determined that the compassionate extubation simulation elicited a statistically significant median increase in C-Scale scores after participation in the simulation (median = 20) compared to C-Scale scores prior (median = 12), W = 45, p = 0.007.
Conclusions
Affording opportunity for healthcare providers to sculpt and refine their practice with certain challenging clinical scenarios has been shown to improve their confidence navigating these situations. All efforts to improve confidence related to sensitive situations such as with a compassionate extubation are made with the intention of improving the experience of children at the end of their lives as well as the experiences of the families and loved ones who walk this journey with them.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2008P - Brazilian real-world data of immunotherapy (IO) in extensive disease small cell lung cancer (ES-SCLC)
Presenter: Flávia Duarte
Session: Poster session 05
2009P - CNS efficacy of immune checkpoint inhibitors when combined to stereotactic radiosurgery in extensive stage small cell lung cancer
Presenter: Muhammad Awidi
Session: Poster session 05
2010P - Non-invasive radiomics signature predicts response to combination chemoimmunotherapy in extensive-stage small cell lung cancer (ES SCLC)
Presenter: Stuthi Perimbeti
Session: Poster session 05
2011P - Machine-derived features of tumor infiltrating lymphocytes (TILs) as biomarkers of clinical outcomes to platinum chemotherapy in small cell lung cancer (SCLC)
Presenter: Prantesh Jain
Session: Poster session 05
2012P - Spatially resolved transcriptomics deciphers inter- and intra-tumor heterogeneity of small cell lung cancer
Presenter: xujie Sun
Session: Poster session 05
2013P - Investigating the clinical relevance of immune checkpoint expression in the peripheral blood of patients with small cell lung cancer (SCLC)
Presenter: Dimitrios Mavroudis
Session: Poster session 05
2014P - ATR inhibition upregulates PD-L1 and potentiates the antitumor immune response to chemoimmunotherapy in small cell lung cancer
Presenter: Triparna Sen
Session: Poster session 05
2015P - Association between gene characteristics and mutation abundance with the prognosis of small cell lung cancer
Presenter: Lian Yu
Session: Poster session 05
2016P - The role of galectin-1 in SCLC: Prognostic significance and therapeutic implications
Presenter: Arancha Cebrian
Session: Poster session 05
2017P - Comprehensive molecular profiling of small cell lung cancer patients treated with chemo-immunotherapy or chemotherapy alone
Presenter: Milena Urbini
Session: Poster session 05